DXCM  valuation analysis

Name: DexCom, Inc
Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 11, 2021
Market cap: $34.24B (185th)
Sales(TTM): $1.93B (691st)
Earnings(TTM): $493.60M (331st)

FFER: 2.21 (why)
Actual price: $356.27
FFEThis is DexCom, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $185.79
Quantile: DXCM is very expensive given its fundamentals.
Prices as of EOD 2021-03-04
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
DexCom, Inc
"Diagnostics & Research" industry
Sales / MarketCap
DexCom, Inc
"Diagnostics & Research" industry
Book / MarketCap
DexCom, Inc
"Diagnostics & Research" industry
Equity / Assets
DexCom, Inc
"Diagnostics & Research" industry